RNA-triggered Cas12a2 antibacterial activity and resistance plasmid degradation

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Antimicrobial resistance (AMR) necessitates programmable antibacterial strategies with novel mechanisms. Here, we evaluated an inducible intracellular CRISPR/Cas12a2 system in engineered Escherichia coli targeting a chloramphenicol-resistance (Chl) transcript. Cas12a2 activation significantly delayed bacterial growth and reduced recoverable colony-forming units (CFU) by 3-log 10 in vitro , and reduced bacterial burdens in a mouse skin wound model. Transcriptomic profiling revealed upregulation of recA , a key mediator of the SOS response. We therefore designed a Chl- recA dual-targeting construct, which produced a greater growth delay than either single-targeting counterpart. The optimized dual-targeting system led to an approximately 4-log 10 reduction in bacterial burden in vivo . Furthermore, exploratory qPCR of culture supernatants suggested a treatment-associated decrease in amplifiable plasmid DNA. Overall, this study provides proof-of-concept for resistance-transcript-guided Cas12a2 antibacterial activity and highlights the potential of co-targeting stress-associated transcripts to enhance programmable antimicrobials.

Article activity feed

  1. RNA-triggered Cas12a2 antibacterial activity and resistance plasmid degradation https://www.biorxiv.org/content/10.64898/2026.11.03.763947v1

  2. RNA-triggered Cas12a2 antibacterial activity and resistance plasmid degradation https://www.biorxiv.org/content/10.64898/2026.11.03.763947v1